Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1048875 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL6587570 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL19766467 | 0.94 | ALDH1A1 (0.43) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL20236042 | 0.91 | USP2 (0.57) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL20236040 | 0.91 | USP2 (0.57) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL31681954 | 0.91 | USP2 (0.57) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL31437014 | 0.87 | ALDH1A1 (0.56) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL17784472 | 0.86 | USP2 (0.48) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL16416073 | 0.86 | USP2 (0.48) | ALDH1A1TSHRUSP2ALOX15KDM4E | |
| SCHEMBL23294916 | 0.84 | ALDH1A1 (0.58) | ALDH1A1TSHRUSP2ALOX15KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503668-B2 | Odorant compound | FIRMENICH SA (CH) | 2025-12-23 | — | — | US | disclosed |
| US-20230227751-A1 | ODORANT COMPOUND | FIRMENICH SA (CH) | 2023-07-20 | — | — | US | disclosed |
| US-20230165973-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | ARBUTUS BIOPHARMA CORPORATION (US) | 2023-06-01 | — | — | US | disclosed |
| CN-109996778-B | Taste modifying aldehydes | 高砂香料工业株式会社 | 2022-12-13 | — | — | CN | disclosed |
| CN-110603240-B | Synthesis of pheromones and related substances via olefin metathesis | 普罗维维公司 | 2022-11-15 | — | — | CN | disclosed |
| US-20200297870-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | ARBUTUS BIOPHARMA CORPORATION (CA) | 2020-09-24 | — | — | US | disclosed |
| EP-3677567-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | Arbutus Biopharma Corporation (CA) | 2020-07-08 | — | — | EP | disclosed |
| CN-110974981-A | Compositions and methods for delivering messenger RNA | 野草莓树生物制药公司 | 2020-04-10 | — | — | CN | disclosed |
| CN-110603240-A | Synthesis of pheromones and related substances via olefin metathesis | 普罗维维公司 | 2019-12-20 | — | — | CN | disclosed |
| US-20160256567-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2016-09-08 | — | — | US | disclosed |
| EP-0823423-A1 | 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-02-11 | — | — | EP | disclosed |
| EP-0232912-B1 | HYDROXAMIC ACIDS OF 7-OXABICYCLOHEPTANE SUBSTITUTED ETHERS | E.R. Squibb & Sons, Inc. (US) | 1992-05-13 | — | — | EP | disclosed |
| EP-0161904-B1 | TETRAHYDROFURANYL AND TETRAHYDROTHIENYL SUBSTITUTED ETHERS | E.R. Squibb & Sons, Inc. (US) | 1989-10-18 | — | — | EP | disclosed |
| EP-0232912-A1 | Hydroxamic acids of 7-oxabicycloheptane substituted ethers | E.R. Squibb & Sons, Inc. (US) | 1987-08-19 | — | — | EP | disclosed |
| US-4654366-A | ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, ANTIPSORIATIC | E. R. SQUIBB & SONS, INC. (US) | 1987-03-31 | — | — | US | disclosed |
| EP-0163562-A1 | 7-Oxabicycloheptane substituted ethers | E.R. Squibb & Sons, Inc. (US) | 1985-12-04 | — | — | EP | disclosed |
| EP-0161904-A2 | Tetrahydrofuranyl and tetrahydrothienyl substituted ethers | E.R. Squibb & Sons, Inc. (US) | 1985-11-21 | — | — | EP | disclosed |
| US-4550120-A | BRONCHODILATOR AGENTS, ANALGESICS | E. R. SQUIBB & SONS, INC. (US) | 1985-10-29 | — | — | US | disclosed |
| US-4542151-A | CARDIOVASCULAR, BRONCHODILATION, ANALGESICS, ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1985-09-17 | — | — | US | disclosed |
| US-4521539-A | ANALGESICS, CARDIONVASCULAR AND ANTIINFLAMMATORY AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1985-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160256567-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | NSUN3, RNMT, RNASE1 | ALDH1A1 4469/4885TSHR 3372/4885USP2 2542/4885 |
| US-20230227751-A1 | ODORANT COMPOUND | TRPA1, ACLY, CYP3A5 | ALDH1A1 220/4885TSHR 4868/4885USP2 2960/4885 |
| US-20200297870-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | NSUN3, CETP, SYNCRIP | ALDH1A1 4595/4885TSHR 2530/4885USP2 3279/4885 |
| US-12503668-B2 | Odorant compound | TRPA1, ACLY, CYP3A5 | ALDH1A1 220/4885TSHR 4868/4885USP2 2960/4885 |
| US-20230165973-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | NSUN3, CETP, SYNCRIP | ALDH1A1 4595/4885TSHR 2530/4885USP2 3279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.